Nonalcoholic steatohepatitis associated with psoriasis vulgaris

Journal of Gastroenterology

Volumn 39, Issue 11, 2004, Pages 1102-1105

  Matsumoto, Teruo ^a   Suzuki, Norihisa ^a   Watanabe, Hiroshi ^a   Irie, Makoto ^a   Iwata, Kaoru ^a   Anan, Akira ^a   Nakane, Hidetoshi ^a   Yoshikane, Makoto ^a   Nishizawa, Shinya ^a   Sohda, Tetsuro ^a   Sakisaka, Shotaro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Insulin resistance; Nonalcoholic steatohepatitis; Psoriasis vulgaris

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; LACTATE DEHYDROGENASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CELL INFILTRATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRINKING BEHAVIOR; ERYTHEMA; GLUCOSE BLOOD LEVEL; HEPATOMEGALY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; INFLAMMATORY CELL; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER DYSFUNCTION; LIVER FIBROSIS; LYMPHOCYTE; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL EXAMINATION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PSORIASIS VULGARIS;

ADULT; DIABETES MELLITUS; FATTY LIVER; HEPATOMEGALY; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; PSORIASIS;

EID: 10244239460     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1451-5     Document Type: Article

References (24)

1. Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
2. Ito S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcholic hepatitis. Am J Gastroenterol 1987; 82:650-4.
3. Diehl AM, Gooman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. Gastroenterology 1988;95:1056-62.
4. Lee RG. Nonalcoholic steatohepatitis. A study of 49 patients. Hum Pathol 1989;20:594-8.
5. Powell EE, Cooksley WGE, Hanson R, Seale J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 1990;11:74-80.
6. Bacon BR, Farahvash MJ, Janney CG, Neuschwander, Tetri BA. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994;107:1103-9.
7. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-92.
8. Angulo P, Lindor KD. Insulin resistance and mitochondrial abnormalities in NASH: A cool look into a burning issue. Gastroenterology 2001;120:1281-5.
9. Krueger GG, Duvic M. Epidemiology of psoriasis: Clinical issues. J Invest Dermatol 1994;102:S14-8.
10. Farber EM, Rein G, Lanigan SW. Stress and psoriasis. Psychoneuroimmunologic mechanisms. Int J Dermatol 1991;30:8-12.
11. Gold MH, Holy AK, Roenigk HH Jr. Beta-blocking drugs and psoriasis: A review of cutaneous side effects and retrospective analysis of their effects psoriasis. J Am Acad Dermatol 1988;19: 837-41.
12. Wolf R, Tamir A, Brenner S. Psoriasis related to angioten-sinconverting enzyme inhibitors. Dermatologica 1990:181:51-3.
13. Barker H. The influence of chloroquine and related drugs on psoriasis and keratoderma blennorrhagicum. Br J Dermatol 1966; 78:161-6.
14. Lazarus GS, Gilgor RS. Psoriasis. Polymorphonuclear leukocytes, and lithium carbonate. An important clue. Arch Dermatol 1979; 115;1183-4.
15. Duvic M, Johnson TM, Rapini RP, Freese T, Brewton G, Rios A. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol 1987;123:1622-32.
16. Swerlick RA, Cunningham MW, Hall NK. Monoclonal antibodies cross-reactive with group A streptococci and normal and psoriatic human skin. J Invest Dermatol 1986;87:367-71.
17. Lindegard B. Diseases associated with psoriasis in a general population of 159200 middle-aged, urban, native Swedes. Dermatologica 1986;172:298-304.
18. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1380 patients. J Invest Dermatol 1988;91:197-201.
19. Zachariae H, Sogaard H. Liver biopsy in psoriasis: A controlled study. Dermatologica 1973;146:149-55.
20. Nyfors A, Poulsen H. Liver biopsies from psoriatics related to methotrexate therapy: Two findings before and after methotrexate therapy in 88 patients. A blind study. Acta Pathol Microbiol Scand A 1976;84:262-70.
21. Brenelli SL, Moraes AM, Monte-Alegre S, Carvalho OMF, Saad MJA. Insulin resistance in psoriasis. Braz J Med Biol Res 1995;28:297-301.
22. Ellis CN, Varani J, Fischer GJ, Zeigler ME, Pershadsingh HA, Benson SC, et al. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: Ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferaton. Arch Dermatol 2000;136:609-16.
23. Caldwell SH, Hespenhide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard BL. A pilot study of a thiazolidinedione, troglitazone, in non alcoholic steatohepatitis. Am J Gastroenterol 2001;96:519-25.
24. Lonardo A, Loria P, Carulli N. Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. Dig Liver Dis 2001;33:86-7.